ELAN

25.7402.09%
ED

Ellen de Brabander

Executive Vice President of Research, Development & Regulatory Affairs

Dr. Ellen de Brabander, Ph.D., serves as Independent Director of Archer-Daniels-Midland Company from May 2023. She serves as an Executive Vice President of Research, Development and Regulatory Affairs at Elanco Animal Health Incorporated since August 2024 and had been its Executive Vice President of Innovation, Regulatory and Business Development until August 2024. Dr. de Brabander joined Elanco in October 2021 and is responsible for global R&D organization as well as overseeing business development and regulatory affairs. She was an Executive Vice President of Innovation and Regulatory Affairs of Elanco Animal Health Incorporated since October 18, 2021. She is a highly experienced R&D leader with a proven background of accomplishments in animal health research and development. She served as Global Head of Merial Research & Development at Merial Limited. and led its global research and new product development activities in nine R&D centers around the world. Dr. de Brabander started her career with DSM, she held successive global senior executive-level positions in the Coating Resins and Chemicals divisions. She served as Chief Executive Officer of DSM's Pharma Chemicals until 2004. She served as Vice President of Corporate Technology for all of DSM. She served as Head of R&D and Board Member for Intervet beginning since 2006, She was responsible for R&D organization, managing the R&D activities in both vaccines and pharmaceuticals. From March 2014 to October 2021, Dr. de Brabander joins Elanco from PepsiCo, serving as senior vice president for R&D Technical Insights, Digital Solutions and Compliance, with global responsibilities at the company. Additionally, Dr. de Brabander spearheaded the company’s R&D digital transformation. Prior to PepsiCo, Dr. de Brabander spent nearly two decades in animal health and pharmaceutical roles leading global R&D organizations at Merial (now Boehringer Ingelheim Animal Health), Intervet (now Merck Animal Health) and the specialty chemical company DSM. She is the co-author of over 60 publications in scientific journals, holds 18 patents and has received multiple awards for her research, including the Golden Medal from the Royal Dutch Chemical Society in 2000 for Best Chemist. Additionally, she was named to last year’s National Diversity Council’s list of Power 50 in the U.S. She holds a master’s degree in Chemistry from Leiden University. Dr. de Brabander earned her Ph.D. cum laude in bio-organic chemistry from Leiden University in the Netherlands and completed post-doctoral work in molecular biology at the Massachusetts Institute of Technology (MIT) in the group of Prof. Dr. H.G. Khorana, a Nobel laureate.

Positions